Target intelligence / Profile preview

Peptidylprolyl isomerase A pseudogene 54 (PPIAP54)

Target
PPIAP54
Molecular classification
Other (Pseudogene)
01

Overview

Peptidylprolyl isomerase A pseudogene 54 (PPIAP54) is annotated as a *pseudogene* in the human genome, meaning it is a genomic sequence similar to the functional gene Peptidylprolyl isomerase A (PPIA) but is presumed nonfunctional due to mutations or lack of coding potential. Pseudogenes can play regulatory roles in rare cases (for instance, as competitive endogenous RNAs), but there is no evidence in the literature or gene databases to support any coding or direct regulatory function for PPIAP54. As a member of a large family of human pseudogenes, its main value is as a genomic reference to its parental gene, not as a therapeutic or diagnostic target. The parental gene, PPIA (cyclophilin A), is an enzyme involved in protein folding and multiple cellular processes, with roles in inflammation and various diseases, but PPIAP54 does not encode this protein and has no implicated role in disease pathogenesis. There are no known drugs, mechanisms of action, or established biomarkers involving PPIAP54.

02

Biological functions

None established for PPIAP54 itself; pseudogenes in general may act as regulatory RNAs or microRNA sponges, but no direct function is reported for PPIAP54
03

Disease associations

None known for PPIAP54. No disease association or biomarker role is reported in current databases.

Beyond the preview

Go deeper on Peptidylprolyl isomerase A pseudogene 54 (PPIAP54).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 54 (PPIAP54).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call